Differences in Corticotropin-Releasing Hormone-Stimulated Adrenocorticotropin and Cortisol before and after Weight Loss

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 6, 1997, Pages 1874-1878

  Yanovski, Jack A ^b,e   Yanovski, Susan Zelitch ^c   Gold, Philip W ^d   Chrousos, George P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OVIS;

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE;

ADULT; ARTICLE; BLOOD; BODY CONSTITUTION; DIET THERAPY; FEMALE; HUMAN; MIDDLE AGED; OBESITY; OSMOLARITY; PATHOLOGY; WEIGHT REDUCTION;

ADRENOCORTICOTROPIC HORMONE; ADULT; BODY CONSTITUTION; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; HYDROCORTISONE; MIDDLE AGED; OBESITY; OSMOLAR CONCENTRATION; WEIGHT LOSS;

EID: 0031156411     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.6.3998     Document Type: Article

References (49)

1. Chong PK, Jung RT, Bartlett WA, Browning MC. 1992 The acute effects of corticotropin-releasing factor on energy expenditure in lean and obese women. Int J Obes Relat Metab Disord. 16:529-534.
2. Brown L, Fisher L. 1985 Corticotropin-releasing factor: effect on the autonomic nervous system and visceral systems. Fed Proc. 44:243-248.
3. Levine A, Rogers J, Kneip J, Grace M, Morley J. 1983 Effect of centrally administered corticotropin-releasing factor (CRF) on multiple feeding paradigms. Neuropharmacology. 22:337-339.
4. Rudman D, Brown S, Malkin M. 1963 Adipokinetic actions of adrenocorticotropin, thyroid stimulating hormone, vasopressin, α- and β-melanocyte-stimulating hormones, fraction H, epinephrine, and norepinephrine in the rabbit, guinea pig, hamster, rat, pig and dog. Endocrinology. 72:527-543.
5. Lonnroth P, Smith U. 1992 Intermediary metabolism with an emphasis on lipid metabolism, adipose tissue, and fat cell metabolism: a review. In: Bjorntorp P Brodoff MN, eds. Obesity. Philadelphia: Lippincott; 3-14.
6. Ng TB. 1990 Studies on hormonal regulation of lipolysis and lipogenesis in fat cells of various mammalian species. Comp Biochem Physiol. 978:441-446.
7. Orth DN, Kovacs WJ, DeBold CR. 1992 The adrenal cortex. In: Wilson JD Foster DW, eds. Williams textbook of endocrinology. Philadelphia: Saunders; 489-619.
8. Gregoire F, Genart C, Hauser N, Remacle C. 1991 Glucocorticoids induce a drastic inhibition of proliferation and stimulate differentiation of adult rat fat cell precursors. Exp Cell Res. 196:270-278.
9. Hauner H, Schmid P, Pfeiffer ER. 1987 Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab. 64:832-835.
10. Dunkelman SS, Fairhurst B, Plagerr J. 1964 Cortisol metabolism in obesity. J Clin Endocrinol Metab. 28:832-836.
11. Glass AR. 1989 Endocrine aspects of obesity. Med Clin North Am. 73:139-160.
12. Grossman A, Hewlett TA, Kopelman PG. 1987 The use of CRF-41 in the differential diagnosis of Cushing's syndrome and obesity. Horm Metab Res. 16(Suppl):62-64.
13. Kopelman PG, Grossman A, Lavender P, Besser GM, Rees LH, Coy D. 1988 The cortisol response to corticotrophin-releasing factor is blunted in obesity. Clin Endocrinol (Oxf). 28:15-18.
14. Bernini GP, Argenio GF, Del Corso C, Vivaldi MS, Birindelli R, Franchi F. 1992 Serotoninergic receptor activation by dextrofenfluramine enhances the blunted pituitary-adrenal responsiveness to corticotropin-releasing hormone in obese subjects. Metabolism. 41:17-21.
15. Trainer PJ, Faria M, Newell-Price J, et al. 1995 A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. J Clin Endocrinol Metab. 80:412-417.
16. Pasquali R, Casimirri F, Cantobelli S, et al. 1993 Beta-endorphin response to exogenous corticotrophin-releasing hormone in obese women with different patterns of body fat distribution. Int J Obes Relat Metab Disord. 17:593-596.
17. Pasquali R, Cantobelli S, Casimirri F, et al. 1993 The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution [see comments]. J Clin Endocrinol Metab. 77:341-346.
18. Hautanen A, Adlercreutz H. 1993 Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J Intern Med. 234:461-469.
19. Vance ML, Thorner MO. 1989 Fasting alters pulsatile and rhythmic cortisol release in normal man. J Clin Endocrinol Metab. 68:1013-1018.
20. Tegelman R, Lindeskog P, Carlstrom K, Pousette A, Blomstrand R. 1986 Peripheral hormone levels in healthy subjects during controlled fasting. Acta Endocrinol (Copenh). 113:457-462.
21. Henson LC, Heber D. 1983 Whole body protein breakdown rates and hormonal adaptation in fasted obese subjects. J Clin Endocrinol Metab. 57:316-319.
22. Fichter MM, Pirke KM. 1986 Effect of experimental and pathological weight loss upon the hypothalamo-pituitary-adrenal axis. Psychoneuroendocrinology. 11:295-305.
23. Fichter MM, Pirke KM, Holsboer F. 1986 Weight loss causes neuroendocrine disturbances: experimental study in healthy starving subjects. Psychiatry Res. 17:61-72.
24. Bergendahl M, Vance ML, Iranmanesh A, Thorner MO, Veldhuis JD. 1996 Fasting as a metabolic stress paradigm selectively amplifies cortisol secretory burst mass and delays the time of maximal nyctohemeral cortisol concentrations in healthy men. J Clin Endocrinol Metab. 81:692-699.
25. Gold PW, Gwirtsman H, Avgerinos PC, et al. 1986 Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. N Engl J Med. 314:1335-1342.
26. Drent ML, Ader HJ, van der Veen EA. 1995 The influence of chronic administration of the serotonin agonist dexfenfluramine on responsiveness to corticotropin releasing hormone and growth hormone-releasing hormone in moderately obese people. J Endocrinol Invest. 18:780-788.
27. Scavo D, Barletta C, Buzzetti R, Vagiri D. 1988 Effects of caloric restriction and exercise on B-endorphin, ACTH and cortisol circulating levels in obesity. Physiol Behav. 42:65-68.
28. Zelissen PM, Koppeschaar HP, Erkelens DW, Thijssen JH. 1991 β-Endorphin and adrenocortical function in obesity. Clin Endocrinol (Oxf). 35:369-372.
29. Howard AN. 1989 The historical development of very-lew calorie diets. Int J Obes. 13:1-9.
30. Foster GD, Wadden TA, Peterson FJ, Letizia KA, Bartlett SJ, Conill AM. 1992 A controlled comparison of three very-low-calorie diets: effects on weight, body composition, and symptoms. Am J Clin Nutr. 55:811-817.
31. Gold PW, Loriaux DL, Roy A, et al. 1986 Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med. 314:1329-1335.
32. Spitzer RL. 1990 User's Guide for the Structured Clinical Interview for DSM-III-R (SCID). Washington DC; American Psychiatric Press.
33. Spitzer RL, Yanovski S, Wadden T, et al. 1993 Binge eating disorder: its further validation in a multisite study. Int J Eat Disord. 13:137-153.
34. Lohman TG, Roche AF, Martorell R. 1988 Anthropometric standardization reference manual. Champaign: Human Kinetics.
35. Optifast program pamphlet. 1990 Nutrient breakdown of Optifast 800. Mineapolis: Sandoz Nutrition Corp.
36. Flack MR, Oldfield EH, Cutler Jr GB, et al. 1992 Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Ann Intern Med. 116:211-217.
37. Nieman LK, Chrousos GP, Oldfield EH, Avgerinos PC, Cutler Jr G, Loriaux DL. 1986 The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome. Ann Intern Med. 105:862-867.
38. Jerkunica I, Sophianopoulos J, Sgoutas D. 1980 Improved ultrafiltration method for determining unbound cortisol in plasma. Clin Chem. 26:1734-1737.
39. Thompson J, Moschella A, Bowers WF. 1981 Evaluation of an ultrafiltration device for free ligand determination. Clin Chem. 27:161-162.
40. Fujieda K, Goff AK, Pugeat M, Strott CA. 1982 Regulation of the pituitary-adrenal axis and corticosteroid-binding globulin-cortisol interaction in the guinea pig. Endocrinology. 111:1944-1950.
41. Yanovski SZ, Yanovski JA, Gwirtsman HE, Bernat A, Gold PW, Chrousos GP. 1993 Normal dexamethasone suppression in obese binge and nonbinge eaters with rapid weight loss. J Clin Endocrinol Metab. 76:675-674.
42. Berger M, Pirke KM, Doerr P, Krieg C, von Zersseen D. 1983 Influence of weight loss on the dexamethasone suppression test. Arch Gen Psychiatry. 40:585-586.
43. Yerevanian BI, Baciewicz GJ, Iker HP, Privitera MR. 1484 The influence of weight loss on the dexamethasone suppression test. Psychiatry Res. 12:155-160.
44. Edelstein CK, Roy-Byrne P, Fawzy FI, Dornfeld L. 1483 Effects of weight loss on the dexamethasone suppression test. Am J Psychiatry. 140:338-341.
45. Azizi F. 1978 Effect of dietary composition on fasting-induced changes in serum thyroid hormones and thyrotropin. Metabolism. 27:935-942.
46. Hendler RG, Walesky M, Sherwin RS. 1986 Sucrose substitution in prevention and reversal of the fall in metabolic rate accompanying hypocaloric diets. Am J Med. 81:280-284.
47. Barrows K, Snook JT. 1987 Effect of a high-protein, very-low-calorie diet on resting metabolism, thyroid hormones, and energy expenditure of obese middle-aged women. Am J Clin Nutr. 45:391-398.
48. Yang MU, Barbosa-Saldivar JL, Pi-Sunyer FX, Van Itallie TB. 1981 Metabolic effects of substituting carbohydrate for protein in a low-calorie diet: a prolonged study in obese patients. Int J Obes. 5:231-236.
49. Davie MW, Abraham RR, Hewins B, Wynn V. 1986 Changes in bone and muscle constituents during dieting for obesity. Clin Sci. 70:285-243.